Hisamitsu Pharmaceutical Co., Inc. (TYO:4530)
Japan
· Delayed Price · Currency is JPY 4,153.00
-13.00 (-0.31%)
At close: Dec 5, 2025
TYO:4530 Revenue
Hisamitsu Pharmaceutical Co. had revenue of 40.28B JPY in the quarter ending August 31, 2025, with 1.59% growth. This brings the company's revenue in the last twelve months to 155.49B, up 3.53% year-over-year. In the fiscal year ending February 28, 2025, Hisamitsu Pharmaceutical Co. had annual revenue of 156.01B with 10.09% growth.
Revenue (ttm)
155.49B
Revenue Growth
+3.53%
P/S Ratio
1.87
Revenue / Employee
55.55M
Employees
2,799
Market Cap
290.91B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Feb 28, 2025 | 156.01B | 14.30B | 10.09% |
| Feb 29, 2024 | 141.71B | 13.38B | 10.42% |
| Feb 28, 2023 | 128.33B | 8.14B | 6.77% |
| Feb 28, 2022 | 120.19B | 5.68B | 4.96% |
| Feb 28, 2021 | 114.51B | -26.48B | -18.78% |
| Feb 29, 2020 | Pro | Pro | Pro |
| Feb 28, 2019 | Pro | Pro | Pro |
| Feb 28, 2018 | Pro | Pro | Pro |
| Feb 28, 2017 | Pro | Pro | Pro |
| Feb 29, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,213.71B |
| HOYA Corporation | 892.50B |
| Takeda Pharmaceutical Company | 4,417.00B |
| Daiichi Sankyo Company | 1,978.88B |
| Otsuka Holdings | 2,418.53B |
| Astellas Pharma | 2,006.82B |
| Terumo | 1,062.42B |
| Shionogi & | 437.26B |